6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (22).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 1×
“If the patient is meeting A1C target, consider one of three strategies (39):”
Background
Cited by
Items 501–600 of 687
Matpady, P., Maiya, A. G., Gaundar, N., Shetty, J. K., Bhojaraja, V. S., Anupama, D. S., & Umakanth, S. (2022) · Journal of Natural Remedies · doi:10.18311/jnr/2022/28166 · Cited by 3
Artificial intelligence in diabetes management
Thomas, A., Gopi, V. P., & Francis, B. (2024) · Advances in Artificial Intelligence · doi:10.1016/b978-0-443-19073-5.00002-1 · Cited by 3
Toschi, E., Edwards, S., Kao, C. Y., Xue, J., Atakov-Castillo, A., Wang, W., Steil, G. M., & Wolpert, H. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0132 · Cited by 3
Tang, R., Kou, M., Li, X., Wang, X., Ma, H., Heianza, Y., & Qi, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15874 · Cited by 3
Validation of cobas ® pulse point-of-care testing device for blood glucose monitoring
Adelhelm, J. B. H., Jørgensen, C. S., Hansen, H. B., Østertoft, S. B., Nybo, M., & Jørgensen, L. H. (2025) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2025.2512382 · Cited by 3
Uncommon Presentations of Diabetes: Zebras in the Herd
Shidler, K. L., Letourneau, L. R., & Novak, L. M. (2019) · Clinical Diabetes · doi:10.2337/cd19-0019 · Cited by 4
Why Are We Stuck? Therapeutic Inertia in Diabetes Education
Cox, C. E., & Isaacs, D. M. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0003 · Cited by 3
Diabetes and Smoking as the Potential Risk Factors for Peri-implant Diseases
Decker, A. M., & Wang, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-39185-0_7 · Cited by 3
Non-insulin therapies in addition to insulin in Type 1 DM treatment
Llano, A., & McKay, G. A. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa011 · Cited by 3
Cystic Fibrosis-Related Diabetes
Granados, A., & Hughan, K. S. (2020) · Respiratory medicine · doi:10.1007/978-3-030-42382-7_16 · Cited by 3
Pancreatic Islet Transplantation: A Surgical Approach to Type 1 Diabetes Treatment
Rodriguez, S., Alexander, M., & Lakey, J. R. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_48 · Cited by 3
Petrovski, G., Khalaf, F. A., Campbell, J., Hussain, K., Day, E., & Pasha, M. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4703 · Cited by 3
Winter, W. E., Pelletier, J. P. R., & Harris, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815499-1.00034-x · Cited by 3
Becerra, L. A., Mendez, B., Khan, F. A., Lioutas, V., Novák, P., Mantzoros, C. S., Ngo, L. H., & Novak, V. (2022) · PubMed · Cited by 4
Ikeda, T., Komiyama, H., Miyakuni, T., Takano, M., & Asai, K. (2024) · Metabolites · doi:10.3390/metabo14040192 · Cited by 2
“HbA1c is commonly used clinically to monitor glycemic control in diabetic patients [33].”
Improving Outcomes in Patients With Diabetes Mellitus
Aguilar, D. A. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.011971 · Cited by 3
Villa-Tamayo, M. F., Colmegna, P. H., & Breton, M. D. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231212205 · Cited by 2
“25 Following these principles, the safety layer is then designed to apply an exponential decay constraint over the insulin delivery dose as a response to the minimum glucose value recorded in the last hour ( ) G min and the current glucose concentration ( ).”
MethodZhang, Z., Lv, D., You, Y., Zhao, Z., Hu, W. M., Xie, F., Lin, Y., Xie, W., & Wu, X. (2024) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_354_23 · Cited by 4
“[24] China also sets HbA1c levels below 7% as a goal in the integrated control targets for T2DM.”
BackgroundOhaegbulam, K. C., Anderson, C., Thompson, R. F., & Митин, Т. (2025) · Clinical Lung Cancer · doi:10.1016/j.cllc.2025.04.012 · Cited by 2
Ranasinghe, M. P., Ranasinghe, M., Balachandran, M., Goel, V., Subasinghe, S., & Nanayakkara, S. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.09.008 · Cited by 3
Glycemic control amongst diabetic subjects on insulin therapy: Still off target!
Shetty, S. B., & Ramachandrappa, L. (2019) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2019.i04.05 · Cited by 2
Deas, C. M., Clark, S. K., & Freeman, M. K. (2020) · INNOVATIONS in pharmacy · doi:10.24926/iip.v11i1.2320 · Cited by 2
Choo, M., Hoy, G. E., Dugan, S. P., McEwen, L. N., Gunaratnam, N. T., Wyckoff, J., Jeevaraaj, T., Saththiyaseelan, A., Ganeikabahu, B., Katulanda, P., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038148 · Cited by 2
Stanojevic, V., Jevtić, M., Mitrović, M., Panajotovic, M., Aleksic, A., & Stanojević, Č. (2021) · Vojnosanitetski pregled · doi:10.2298/vsp211011104s · Cited by 2
A self-report measure of diabetes-specific anxiety symptoms for adolescents
Rechenberg, K., Szalacha, L. A., & Bugajski, A. (2022) · Children s Health Care · doi:10.1080/02739615.2022.2047970 · Cited by 3
“Thus, adequate self-management is paramount in both the short and long-term for adolescents with T1D (Cefalu et al., 2019; Cleary, Dahms, Goldstein, Malone, & Tamborlane, 2001).”
BackgroundDayan, C. M., & Platts, J. K. (2020) · doi:10.1093/med/9780198746690.003.0259 · Cited by 3
The implementation of modern technology into standard of care of type 1 diabetes
Petruželková, L., Plachý, L., Kajprová, M., Neuman, V., Obermannová, B., Průhová, Š., Lebl, J., Koloušková, S., & Šumník, Z. (2022) · Česko-slovenská pediatrie · doi:10.55095/cspediatrie2022/010 · Cited by 2
Öztop, N., Üzüm, A. K., Çelik, S. G., İdiz, C., Tütüncü, Y., Bağdemir, E., & Dınççağ, N. (2023) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.1193997 · Cited by 2
Arifin, A., Thambiah, S. C., Abdullah, H., Samsudin, I. N., & Zahari-Sham, S. Y. (2022) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.18.s21.4 · Cited by 4
Role of mean platelet volume in patients with type 2 diabetes mellitus
Thakur, A., Adhikari, P., Dahal, M., Upadhyaya, P., Karki, S., & Pradhan, A. (2023) · Indian Journal of Pathology and Oncology · doi:10.18231/j.ijpo.2023.028 · Cited by 2
How should we differentiate hypoglycaemia in non-diabetic patients?
Modestino, M. R., Iacono, O., Ferrentino, L., Lombardi, A., Fortuna, U. D., Verdoliva, R., Luca, M. D., & Guardasole, V. (2024) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2024-0030 · Cited by 5
Ahmed, O. A. (2024) · International Journal of Secondary Metabolite · doi:10.21448/ijsm.1332875 · Cited by 2
Ertugliflozin in type 2 diabetes: a profile of its use
Scott, L. J. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00651-7 · Cited by 2
Che, Q., Zhang, Y., Wang, J., Wan, Z., Fu, X., Chen, J., Yan, H., Chen, Y., Ge, J., Chen, D., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13287 · Cited by 3
Pereira, C. A., Almeida, R., & Dores, J. M. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.150 · Cited by 2
de Valk, H. W., Feher, M. D., Hansen, T. K., JENDLE, J. H., Koefoed, M. M., Rizi, E. P., Zimmermann, E., & Fadini, G. P. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00875-1 · Cited by 2
Prevalence and management of diabetes among the uninsured: A multicenter study in Tampa Bay, FL
Joud, H., Mohamed, E., Mirza, S., Tabbaa, H., Tabbaa, M., Khan, F., Ayoubi, N., MacDonald, M., Woodard, L. J., Oxner, A. Z., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108560 · Cited by 2
Saiki, Y., Ojima, T., Kabata, T., Kubo, N., Hayashi, S., & Tsuchiya, H. (2021) · Modern Rheumatology · doi:10.1080/14397595.2020.1868688 · Cited by 2
Impact of heterozygous hemoglobin E on six commercial methods for hemoglobin A1c measurement
Yong, S., Liu, H., Lum, C. L. T., Liu, Q., Sim, S., Chay, F. F. M., Cheng, W. L., Neo, S. F., Chew, S., Ong, L., et al. (2021) · PeerJ Analytical Chemistry · doi:10.7717/peerj-achem.9 · Cited by 2
Paranjpe, R., Johnson, M. L., Chen, H., Birtcher, K. K., Serna, O., Mohan, A., & Abughosh, S. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00543-4 · Cited by 2
Davidson, M. B. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13815 · Cited by 2
Chronic Kidney Disease—How Does It Go, and What Can We Do and Expect?
Chang, L., & Chang, J. (2023) · Biomedicines · doi:10.3390/biomedicines11030977 · Cited by 2
Key Features of Insulin Delivery Devices for Type 2 Diabetes: Type 2.0 Booth Survey
Sze, D., & Oliveria, T. (2019) · Clinical Diabetes · doi:10.2337/cd19-0014 · Cited by 1
The ketogenic diet in health and disease
Rajiyah, T., & Pannain, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816918-6.00025-1 · Cited by 1
Almeida, P. H. R. F., Godman, B., Nogueira, V. D. S. N., de Lemos, L. L. P., Acúrcio, F. D. A., Guerra, A. A., de Araújo, V. E., Almeida, A. M., & Álvares-Teodoro, J. (2022) · Clinical Diabetes · doi:10.2337/cd21-0068 · Cited by 1
Barana, L., Colleluori, G., Sulpizi, M. T., Ortenzi, K., Farano, L., Fanelli, C. G., Calafiore, R., Ragione, L. D., & Pampanelli, S. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01085-1 · Cited by 2
Majumdar, M., Banerjee, M., Sengupta, J., Deb, S., Jana, C. K., & Roy, B. K. (2023) · International Journal of Advanced Research · doi:10.21474/ijar01/17167 · Cited by 1
Diabetes Management in the Emergency Department
Gottlieb, D., Silverman, R., & Schulman‐Rosenbaum, R. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_11 · Cited by 1
Herb, T., Taylor, A. S., Li, S., Manthei, D. M., & Gherasim, C. (2024) · Laboratory Medicine · doi:10.1093/labmed/lmad113 · Cited by 1
Al-Naseri, R. F., Alibrahim, N. T. Y., Al-Salait, S. K. A., & Mansour, A. A. (2025) · Cureus · doi:10.7759/cureus.77374 · Cited by 1
Seo, H., Yoon, W., Kim, J. H., Shin, B. C., Kim, H. L., Son, M., & Yoon, Y. (2025) · Bioengineering · doi:10.3390/bioengineering12101099 · Cited by 2
“Uncontrolled diabetes, characterized by persistent hyperglycemia (glycated hemoglobin [HbA1c] ≥ 7%), significantly increases the risk and progression of diabetes-related complications [10,11].”
Validity and Reliability of the Turkish Version of the Glucose Monitoring Satisfaction Survey
Bilgehan, T., & Toygar, İ. (2025) · Hitit Medical Journal · doi:10.52827/hititmedj.1704087 · Cited by 1
Hamrah, M. H., Song, Z., Hong, Y.-J., Akter, T., Nuamah, H. G., Gondo, N., Matsunaga, M., Ota, A., Takada, M., Otsuka, R., et al. (2025) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.25-00284 · Cited by 1
“Nevertheless, fasting blood glucose (FBG) level is a critical marker of glucose control status [6, 7].”
Wang, X., Wu, Z., Bai, S., Shao, S., Liu, B., Wu, C., & Sun, K. (2026) · ACS Sensors · doi:10.1021/acssensors.5c03623 · Cited by 1
A robust tube-based MPC approach for safer insulin dosing
Licini, N., Santos, M. A., Previdi, F., & Ferramosca, A. (2026) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2026.100393 · Cited by 2
Begum, G. S., Al-Risi, E. S., Al-Maqbali, S., Marakala, V., Subramaniam, G., Agarwal, A., Suhail, N., Hafiz, M. N., & Jawad, M. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15051844 · Cited by 1
“Poor glycemic control, indicated by elevated HbA1c, promotes chronic inflammation and oxidative stress, leading to increased neutrophil-to-lymphocyte ratio (NLR) [9].”
Kaibagarova, I., Ablakimova, N., Smagulova, G., Мавлюдова, Н. М., Mussina, A. Z., Ovsiannikova, A. N., Sartayeva, A., & Zhamaliyeva, L. M. (2026) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2026.28.1.006 · Cited by 1
Jones, P. J., Armstrong, D. G., Rowlands, A. V., Sourij, H., Noormandi, A., & Theodorakopoulos, G. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70198 · Cited by 1
Ghaffarian-Ensaf, R., Mirzababaei, A., Abaj, F., Khadem, A., Noori, S., Jadidi, P., George, E. S., Daneshzad, E., & Mirzaei, K. (2026) · Nutrition & Food Science · doi:10.1108/nfs-08-2025-0283 · Cited by 1
Type 2 Diabetes Mellitus Management in Older Adults with Dementia
Sohail, M., James, K., & Munshi, M. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-46398-4_6 · Cited by 2
Meade, L. T., & Mannka, M. L. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019857557 · Cited by 1
Livingston, E. H. (2019) · JAMA · doi:10.1001/jama.2019.14577 · Cited by 1
Abdelrahim, H. M., Madani, A. M., Mahmoud, A. N., El-Hadiyah, T. M., & Yousif, A. K. (2019) · Pharmacology & Pharmacy · doi:10.4236/pp.2019.1010037 · Cited by 1
Kamrul-Hasan, A. B. M., & Paul, A. (2020) · Journal of Diabetology · doi:10.4103/jod.jod_27_19 · Cited by 2
Batais, M. A., Almutairi, K. M., Almigbal, T. H., Alodhayani, A. A., Alonazi, W. B., Vinluan, J. M., Asnar, J. B., Salem, R. E., & Aljubab, R. A. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420958976 · Cited by 1
Alqahtani, N., Ghazwani, E. Y., Al‐Qahtani, A. M., & Helaly, M. (2020) · Integrative Journal of Medical Sciences · doi:10.15342/ijms.7.215 · Cited by 1
A1C Reduction in Patients Who Declined Pharmacist-Led Diabetes Management Services
Ahmed, F., Hammad, S., Lin, J., Gennaro, T. L., Gaspard, A. L., Sarpong, D. F., & Onor, I. O. (2021) · Journal of Pharmacy Practice · doi:10.1177/0897190021993390 · Cited by 1
Shetty, P., Shetty, S., Shashikiran, H. C., & Rajany, T. (2021) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2021.07.002 · Cited by 1
MERCADO-ASIS, L. B. (2021) · Series of Endocrinology Diabetes and Metabolism · doi:10.54178/jsedmv3i2004 · Cited by 1
Assessment of Glycemic Control at St. Luke’s Free Medical Clinic: Retrospective Chart Review
Hopper, W. A., Fox, J., & DiMucci-Ward, J. (2021) · Interactive Journal of Medical Research · doi:10.2196/31123 · Cited by 1
Pundyk, K. J., & Marks, S. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-52215-5_8 · Cited by 1
New therapies for diabetes mellitus
Barbieri, M., Cataldo, V., Griffing, G. T., & Paolisso, G. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch87 · Cited by 1
Raharinavalona, S. A., Raherison, R. E., Razanamparany, T., Rasoaniana, D., Andrianasolo, R. L., & Rakotomalala, A. D. P. (2022) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2022.2074123 · Cited by 1
Safety and Performance of Continuous Glucose Monitoring: An Overview
Venkatesan, V., & Singh, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220525111746 · Cited by 2
Archie, C. N., Das, D., Meskaran, F., & David, L. G. (2022) · International Conference on Distributed Computing and Electrical Circuits and Electronics (ICDCECE) · doi:10.1109/icdcece53908.2022.9792995 · Cited by 1
The role Time in range depending on the method of assessing glycemic control in diabetes: A review
Суплотова, Л. А., Сергеевна, С. А., & Сергеевна, Д. Т. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.4.201674 · Cited by 1
Hypoglycemia Management Using a Bundled Care Approach: A Quality Improvement Project
Mattathil, R. (2022) · Journal of Nursing Care Quality · doi:10.1097/ncq.0000000000000670 · Cited by 1
Martín‐Payo, R., González‐Nuevo, C., Cano, C. P., Suárez-Lada, C., Padrino-Ojea, S., & Fernandez-Alvarez, M. D. M. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0054 · Cited by 1
Alenazi, F., Peddle, M., Bressington, D. T., Mahzari, M. M., & Gray, R. J. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01294-2 · Cited by 1
Maji, S., Mohanty, R. R., & Maiti, R. (2023) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2023.2023-7-84 · Cited by 1
Watanabe, Y., Yamaguchi, T., Sasaki, A., Naitoh, T., Matsubara, H., Yokote, K., Okazumi, S., Ugi, S., Yamamoto, H., Ohta, M., et al. (2024) · Diabetology International · doi:10.1007/s13340-024-00767-w · Cited by 1
Zhang, L., Gao, X., Meng, X., Ma, G., Li, J., Wang, W., Chen, S., Ma, Y., Yu, P., & Zhou, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1500660 · Cited by 1
Sex-Specific Factors Influencing GrimAge Acceleration in Middle-Aged Korean Adults
Kim, S., & Park, J. (2025) · Biological Research For Nursing · doi:10.1177/10998004251370671 · Cited by 1
“HbA1C was classi fi ed into <6.5% and ≥ 6.5% categories, based on diagnostic thresholds for diabetes (American Diabetes Association, 2019; Qaseem et al., 2018).”
InfluentialSzérum kromogranin A szint vizsgálata 2-es típusú cukorbetegségben
Herold, Z., Herold, M., Doleschall, M., & Somogyi, A. (2020) · Diabetologia Hungarica · doi:10.24121/dh.2020.9 · Cited by 1
Kyriacou, A., Evans, J. M. M., & Kyriacou, A. (2017) · Endocrine Abstracts · doi:10.1530/endoabs.49.ep481 · Cited by 1
A PRACTICAL MODEL FOR EARLY IDENTIFICATION OF PROSPECTIVE HIGH NEED HIGH COST PATIENTSPreprint
Golan‐Cohen, A., Vinker, S., Isaacson, A., Avramovich, E., & Merzon, E. (2022) · medRxiv · doi:10.1101/2022.02.04.22270056 · Cited by 1
Diabetes Awareness Among Coronary Artery Disease Patients Is Higher in Women Than in Men
Saely, C. H., MADER, A., Heinzle, C. F., Zanolin-Purin, D., LARCHER, B., Vonbank, A., & Drexel, H. (2019) · Diabetes Care · doi:10.2337/dc19-0241
Strategies to mitigate hypoglycaemia in the artificial pancreas
Bondía, J., & Vehí, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00018-1
Monteiro, A. I. P. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/rckv-qm36
Carbohydrate Counting or Healthy Eating Plan: Which to Use?
Drago, L., & Waldbillig, N. (2019) · AADE in Practice · doi:10.1177/2325160319877868
Managing Older Adults with Type 2 Diabetes
Hershey, D. S. (2020) · Advances in Family Practice Nursing · doi:10.1016/j.yfpn.2020.01.001
On the need of the simultaneous control of arterial hypertension and diabetes mellitus
Ruilope, L. M., Rodríguez‐Sánchez, E., & Ruiz‐Hurtado, G. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13794
Dove, A. E. (2019) · Työväentutkimus Vuosikirja
Gordillo, A. F. (2019) · Gredos (University of Salamanca)
Bala, C. G. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0036
Self-Management Status in Patients with Diabetes and Disease Control Indicators in Lamerd City, Iran
Jahangir, F., Kavi, E., Masmouei, B., Bazrafshan, M.-R., Delam, H., Shokrpour, N., Namjoonasab, M., Foruozandeh, H., & Zarei, E. (2020) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc.99992
Condition assessment of patients with type 1 diabetes using compositional data analysis
Biagi, L. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Khanam, P. A., Begum, T., Khan, M. M. A., Habib, S. H., & Khan, A. K. A. (2020) · Bangladesh Critical Care Journal · doi:10.3329/bccj.v8i1.47706
Lobato, C. B. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/4zpa-yr60
Mirzazada, V., Huseynova, R., Mustafayeva, S., Gasimova, F., Ahmadova, U., Ismayilova, N., Kerimova, V., Mehdiyeva, H., Suleymanova, R., Maharramova, Z., et al. (2020) · Journal of Diabetology · doi:10.4103/jod.jod_5_20 · Cited by 1
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-12-07
- Volume
- 42
- Issue
- Supplement_1
- Pages
- S61-S70
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4250208868
- Cited by
- 655
- References
- 59
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 35 · 2023: 57 · 2022: 85 · 2021: 117 · 2020: 202 · 2019: 112
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, glycemic control, diabetes management, clinical guidelines, quality of care, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Societies, Medical, United States, Practice Guidelines as Topic, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.